Skip to main content
SpringerLink
Log in

Tumor-mediated immunosuppression is a challenge in cancer treatment

  • Guest Editorial
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Allison, A. C., Berman, L. D., Levy, R. H.: Increased tumor induction by adeno virus type 12 in thymectomized mice, and mice treated with antilymphocyte serum. Nature 125, 185 (1967)

    Google Scholar 

  2. Baldwin, R. W., Pimm, M. V.: BCG suppression of pulmonary metastasis from primary rat hepatoma. Br. J. Cancer 30, 473 (1974)

    Google Scholar 

  3. Behling, U. H., Novotny, A.: Immune adjuvance of lipopolysaccharide and a nontoxic hydrolytic product demonstrating oscillating effects with time. J. Immunol. 118, 1905 (1977)

    Google Scholar 

  4. Behling, U. H., Nowotny, A.: Long-term adjuvant effect of bacterial endotoxin in prevention and restoration of radiation-caused immunosuppression. Proc. Soc. Exp. Biol. Med. 157, 348 (1978)

    Google Scholar 

  5. Benjamin, E., Sluka, E.: Antikörperbildung nach experimenteller Schädigung des hämatopoetiscehen Systems durch Röntgenstrahlen. Wien. Klin. Wochenschr. 21, 311 (1970)

    Google Scholar 

  6. Bennet, M., Steeves, R. A.: Incompetence cell function in mice infected with Friend leukemia virus. J. Natl. Cancer Inst. 44, 1107 (1970)

    Google Scholar 

  7. Burnet, F. M.: The concept of immunological surveillance. Prog. Exp. Tumor Res. 13, 1 (1970)

    Google Scholar 

  8. Buskirk, H. H., Crim, J. A., Petering, H. G., Merritt, K., Johnson, A. G.: Effect of uracil mustard and several antitumor drugs on the primary antibody responses in rats and mice. J. Natl. Cancer Inst. 34, 747 (1965)

    Google Scholar 

  9. Chan, P. L., Sinclair, W. R.: Immunologic and virologic properties of chemically and X-irradiation-induced thymic lymphomas in mice. J. Natl. Cancer Inst. 48, 1629 (1972)

    Google Scholar 

  10. Chanmougan, D., Schwartz, R. S.: Enhancement of antibody synthesis by 6-mercaptopurine. J. Exp. Med. 124, 363 (1966)

    Google Scholar 

  11. Cline, N. J., Haskell, C. M.: In: Cancer chemotherapy, p 22. Philadelphia, London, Toronto: Saunders 1975

    Google Scholar 

  12. Cooperband, S. R., Nimberg, R., Schmid, K.: Humoral immunosuppressive factors. Transplant. Proc. 8, 225 (1976)

    Google Scholar 

  13. Dent, P. B., Lin, V. K., Liao, S. K., McCulloch, P. B.: Inhibitor of nucleotide uptake by normal stimulated lymphocytes produced by cultured melanoma cells. Proc. Am. Assoc. Cancer Res. 17, 125 (1976)

    Google Scholar 

  14. Dent, P. B., Liao, S. K., Ettin, G., Cleland, G. B.: Characterization of an inhibitor of thymidine uptake produced by cultured human melanoma cells. Oncology 35, 235 (1978)

    Google Scholar 

  15. Eilber, F. R., Morton, D. L.: Impaired immunological reactivity and recurrence following cancer surgery. Cancer 25, 362 (1970)

    Google Scholar 

  16. Eilber, F. R., Nizze, J. A., Morton, D. L.: Sequential evaluation of general immune competence in cancer patients: Correlation with clinical course. Cancer 35, 660 (1975)

    Google Scholar 

  17. Eilber, F. R., Homes, E. C., Morton, D. L.: Immunotherapy as an adjuvant to surgery in the treatment of cancer. World J. Surg. 5, 547 (1977)

    Google Scholar 

  18. Gaal, D., Nowotny, A.: Immune enhancement by tumor-therapeutic drugs and endotoxins. Cancer Immunol. Immunother. 6, 9 (1979)

    Google Scholar 

  19. Gatti, R. A., Good, R. A.: Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer 28, 89 (1971)

    Google Scholar 

  20. Golub, S. H., O'Connell, T. X., Morton, D. L.: Correlation of in vivo and in vitro assays of immunocompetence in cancer patients. Cancer Res. 34, 1833 (1974)

    Google Scholar 

  21. Good, R. A., Finstad, J.: Essential relationship between the lymphoid system, immunity and malignancy. Natl. Cancer Inst. Monogr. 31, 41 (1968)

    Google Scholar 

  22. Grand, N. G., Hakim, A. A.: Paradoxical dose response of BCG-vaccine on Sarcoma P 1798 in vitro and in vivo. Am. Fed. Clin. Res. 22, 419 (1974)

    Google Scholar 

  23. Hakim, A. A.: Cell surface antigens and tumor immunology. I. Effect of neuraminidase-treated sarcoma cells on mouse spleen cellular population. Int. Res. Commun. Service 2, 1714 (1974)

    Google Scholar 

  24. Hakim, A. A.: Lymphocyte stimulation by a mammary-carcinoma-associated glycoprotein. Immunol. Commun. 4, 251 (1975)

    Google Scholar 

  25. Hakim, A. A.: Thermal injury: Release of a cytotoxic factor. Experientia 29, 865 (1975)

    Google Scholar 

  26. Hakim, A. A.: Isolation of a protease from cell-free medium of in vitro cultured human mammary carcinoma. Experientia 32, 1057 (1976)

    Google Scholar 

  27. Hakim, A. A.: Modification of the immunogenic properties of the cell surface. Immunol. Commun. 7, 25 (1978)

    Google Scholar 

  28. Hakim, A. A.: Isolation of a growth-stimulating agent from human skin fibroblasts. Experientia 34, 1515 (1978)

    Google Scholar 

  29. Hakim, A. A.: Correlation between immunosuppression to tumorigenesis. 1. Humoral immunosuppressing factor. Eur. J. Cancer 14, 1249 (1978)

    Google Scholar 

  30. Hakim, A. A.: Immunostimulating-immunosuppressing factors released from mixed cultures of lymphocytes and tumor cells. Proc. Am. Assoc. Adv. Sci. 145, 412 (1979)

    Google Scholar 

  31. Hakim, A. A., Grand, N. G.: Immuno-physiologic mechanisms by which neoplasms avoid destruction by the immune systems: Action of Bacillus Calmette Guérin (BCG). Fed. Am. Soc. Exp. Biol. Fed. Proc. 34, 382 (1975)

    Google Scholar 

  32. Hakim, A. A., Grand, N. G.: Mechanism of action of Bacillus Calmette Guérin vaccine on neoplastic proliferation and host immune responses. J. Pharm. Sci. 65, 339 (1976)

    Google Scholar 

  33. Halle-Panneko, O., Bourut, C., Kamel, M.: Comparison of various BCG preparations in the EORTC-ICIG experimental screening for systemic immunity adjuvants applicable to cancer immunotherapy. Cancer Immunol. Immunother. 1, 17 (1976)

    Google Scholar 

  34. Harris, J., Bogai, R. C.: Immunodeficiency states associated with malignant disease in man. Med. Clin. North Am. 56, 501 (1972)

    Google Scholar 

  35. Hersh, E. M., Gutterman, J. H., Mavligit, G. M.: BCG-vaccine and its derivatives. JAMA 235, 646 (1976)

    Google Scholar 

  36. Hrsak, I., Marotti, T.: Immunosuppression by Ehrlich ascites fluid. Eur. J. Cancer 9, 717 (1973)

    Google Scholar 

  37. Ikonopisov, R. L., Lewis, M. G., Hunter-Graig, I. E.: Autoimmunization with irradiated tumor cells in human malignant melanoma. Br. Med. J. 1970 3, 752

    Google Scholar 

  38. Jones, P. D. E., Cantro, J. E.: Immunological mechanisms in metastatic spread and antimetastatic effects of C. parvum. Br. J. Cancer 35, 519 (1977)

    Google Scholar 

  39. Jose, D. G., Seshadri, R.: Circulating immune complexes in human neuroblastoma: Direct assay and role in blocking specific cellular immunity. Int. J. Cancer 13, 824 (1974)

    Google Scholar 

  40. Kamo, I., Patel, L., Kately, J.: Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts. J. Immunol. 114, 1749 (1975)

    Google Scholar 

  41. Law, D. D., Dudrick, S. B., Abdou, N. I.: The effect of dietary protein depletion on immunocompetence. Ann. Surg. 179, 168 (1974)

    Google Scholar 

  42. Likhito, V. V.: Rejection of mammary adenocarcinoma cell tumors and the prevention of progressive growth of incipient metastases following intratumor permeation with killed Bordetella pertussis. Cancer Res. 34, 2790 (1974)

    Google Scholar 

  43. Lin, V. K., Dent, P. B., Liao, S. K.: Characterization of human malignant melanoma cell lines. VI. Inhibition of 3H-thymidine uptake by normal stimulated lymphocytes. Oncology 34, 251 (1977)

    Google Scholar 

  44. McCarty, R. E., Coffin, J. M., Gates, S. L.: Selective inhibition of the secondary immune response to mouse skin allografts by cell-free Ehrlich ascites carcinoma fluid. Transplantation 6, 737 (1968)

    Google Scholar 

  45. Mackhann, C. F., Hendrickson, C. G., Spitler, L. E., Gunvarson, A., Banerjee, R., Nelson, W. R.: Immunotherapy of melanoma with BCG: Two fatalities following intralesional injection. Cancer 35, 514 (1975)

    Google Scholar 

  46. Menzonian, J. O., Scheinman, L., Glasgow, A. H., Saporosachetz, I., Mannick, J. A.: Skin test reactivity and in vitro immunosuppressive activity of serum of cancer patients. Surg. Forum 24, 309 (1973)

    Google Scholar 

  47. Merrick, K., Johnson, A. G.: Studies on the adjuvant of bacterial endotoxin on antibody formation. V. The influence of endotoxin on 5-fluoro-2-deoxyuridine on the primary antibody response of the BALB/c mouse to a purified protein antigen. J. Immunol. 91, 266 (1963)

    Google Scholar 

  48. Merrit, K., Johnson, A. G.: Types of antibody elevated by 5-fluoro-2'-deoxyuridine and endotoxin during the primary response of the mouse. Proc. Soc. Exp. Biol. Med. 115, 1132 (1964)

    Google Scholar 

  49. Miles, L., Hunter, N., Basic, I., Withers, H. R.: Protection by Corynebacterium granulosum against radiation-induced enhancement of artificial pulmonary metastasis of a murine fibrosarcoma. J. Natl. Cancer Inst. 52, 1875 (1974)

    Google Scholar 

  50. Millman, I., Maguire, H. C., Jr., Youmans, G. P., Youmans, A. S.: Effect of the H37 Ra strain of M. tuberculosis and a mycobacterial RNA fraction on tumor growth. Proc. Soc. Exp. Biol. Med. 147, 765 (1974)

    Google Scholar 

  51. Morton, D. L., Joseph, W. L., Kotcham, A. S.: Surgical resection and adjunctive immunotherapy for selected patients with multiple pulmonary metastases. Ann. Surg. 178, 360 (1973)

    Google Scholar 

  52. Namba, M., Ogura, T., Hirao, F., Yamamura, Y.: Immunosuppressive activity of the basic protein from tumor tissue. Gann 68, 751 (1977)

    Google Scholar 

  53. National Institutes of Health (USA): Only oncologists in clinical trials should use BCG vaccine for cancer treatment. JAMA 241, 24 (1979)

    Google Scholar 

  54. Nimberg, R. B., Glasgow, A. H., Menzoian, J. O., Constantion, M. B., Cooperband, S. R., Mannick, J. A., Schmid, K.: Isolation of an immunosuppressive peptide from the serum of cancer patients. Cancer Res. 35, 1489 (1975)

    Google Scholar 

  55. North, R. J., Kirstein, D. P., Tutte, R. L.: Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J. Exp. Med. 143, 559 (1976)

    Google Scholar 

  56. Occhino, J., Glasgow, A. H., Cooperband, S. R., Mannick, J. A., Schmid, K.: Isolation of an immunosuppressive peptide from human plasma. J. Immunol. 110, 685 (1973)

    Google Scholar 

  57. Orita, K., Miwa, H., Maunami, T., Konaga, E., Yumura, M., Fukuda, H., Ucevida, Y., Nakahara, H., Hayashi, S.: Cancer immunotherapy with surgery. Acta Med. Okoyama 31, 217 (1977)

    Google Scholar 

  58. Penn, I., Starze, T. E.: Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 14, 407 (1972)

    Google Scholar 

  59. Petranyi, G., Nouza, K., Szollar, J., Institoris, L.: Immunosuppressive effect of cytostatic diastereomeric dibromohexitols. Folia Biol. (Praha) 15, 366 (1969)

    Google Scholar 

  60. Pikovsky, M. A., Ziffroni-Gallon, Y., Witz, I. P.: Suppression of immune response to sheep red blood cells in mice treated with preparations of a tumor cell component and in tumor-bearing mice. J. Immunol. 115, 447 (1975)

    Google Scholar 

  61. Prager, M. D.: Immune response to modified tumor cells. In: Cellular membranes and tumor cell behavior, pp 523–540. Baltimore: Williams and Wilkins 1976

    Google Scholar 

  62. Prehn, R. T.: Immunosurveillance, regeneration and oncogenesis. Prog. Exp. Tumor Res. 14, 1 (1971)

    Google Scholar 

  63. Prehn, R. T.: Perspective on oncogenesis. Does immunity stimulate or inhibit neoplasia? J. Reticuloendothel. Soc. 10, 1 (1971)

    Google Scholar 

  64. Prehn, R. T.: The immunoreaction as a stimulator of tumor growth. Science 176, 170 (1972)

    CAS  PubMed  Google Scholar 

  65. Prehn, R. T.: Tumor progression and homeostasis. Adv. Cancer Res. 23, 203 (1976)

    Google Scholar 

  66. Prehn, R. T.: Immunostimulation of the lymphodependent phase of neoplastic growth. J. Natl. Cancer Inst. 59, 1045 (1977)

    Google Scholar 

  67. Prehn, R. T., Lappe, M. A.: An immunostimulation theory of tumor development. Transplant. Rev. 7, 26 (1971)

    Google Scholar 

  68. Robins, R. A., Baldwin, R. W.: Immune complexes in cancer. Cancer Immunol. Immunother. 4, 1 (1978)

    Google Scholar 

  69. Santos, G. W.: Immunosuppressive drugs. I. Fed. Proc. 26, 907 (1967)

    Google Scholar 

  70. Schwartz, R. (ed.): Proceedings of the Symposium on Immunosuppressive Drugs. Fed. Proc. 26, 897 (1967)

  71. Sher, N. A., Chapas, S. D., Pearson, J., Chirigos, M.: Virulence of six strains of Mycobacterium bovis (BCG) in mice. Infect. Immun. 8, 736 (1973)

    Google Scholar 

  72. Siegel, B. V., Morton, J. I.: Depressed antibody response in the mouse infected with Rauscher virus. Imunology 10, 559 (1966)

    Google Scholar 

  73. Simmons, R. L., Rios, A.: Immunotherapy of cancer-immuno-specific rejection of tumors in recipients of neuraminidase-treated tumor cells. Science 174, 591 (1971)

    Google Scholar 

  74. Spitalny, G. L., North, R. J.: Subversion of host defense mechanisms by malignant tumors: An established tumor as a privileged site for bacterial growth. J. Exp. Med. 145, 1264 (1977)

    Google Scholar 

  75. Stein, J. A., Siletzki-Ciechanover, M., Gefel, A., Adler, A., Michaeli, D.: Untoward fatal hemorrhagic diathesis in a BCG-treated melanoma patient. Cancer Immunol. Immunother. 4, 269 (1978)

    Google Scholar 

  76. Stewart, A. M.: Tuberculin reaction in cancer patients: ‘Mantoux Release,’ and lymphosuppressive-stimulatory factors. J. Natl. Cancer Inst. 50, 625 (1973)

    Google Scholar 

  77. Streilein, J. W.: Immunotherapy for cancer. Surg. Gynecol. Obstet. 147, 769 (1978)

    Google Scholar 

  78. Subramian, C., Yu, S., McKhann, C. F.: Soluble suppressor factor from the spleens of tumor-bearing mice. Cancer Res. 38, 1996 (1978)

    Google Scholar 

  79. Taliafeno, W. H., Taliafeno, L. G.: Effects of X-rays on immunity: A review. J. Immunol. 66, 181 (1951)

    Google Scholar 

  80. Waldman, T. A., Strober, W., Blease, R. M.: Immunodeficiency disease and malignancy: Various immunologic deficiencies of man and the role of immune processes in the control of malignant disease. Ann. Intern. Med. 77, 605 (1972)

    Google Scholar 

  81. Wong, A., Mankovitz, R., Kennedy, J. L.: Immunosuppressive and immunostimulatory factors produced by malignant cells in vitro. Int. J. Cancer 13, 530 (1974)

    Google Scholar 

  82. Yamazaki, H., Nitta, K., Umozawa, H.: Immunosuppression induced with cell-free fluid of Ehrlich ascites and its fractions. Gann 64, 83 (1973)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Surgery, Oral Diagnosis, Physiology and Biophysics, University of Illinois at the Medical Center, Chicago, Illinois, USA

    A. A. Hakim

Authors
  1. A. A. Hakim
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hakim, A.A. Tumor-mediated immunosuppression is a challenge in cancer treatment. Cancer Immunol Immunother 7, 1–6 (1979). https://doi.org/10.1007/BF00205402

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205402

Search

Navigation